-+ 0.00%
-+ 0.00%
-+ 0.00%

OCULAR THERAPEUTIX INC - PLANS TO SUBMIT ITS NDA UNDER 505(B)(2) PATHWAY, WITH POTENTIAL TO ACCELERATE REVIEW TIMELINE BY UP TO 60 DAYS

Reuters·06/17/2026 12:45:00

Please log in to view news